Related Experiment Video
Updated: May 23, 2026
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Cancer theranostic platforms based on injectable polymer hydrogels.
Feifei Wang1, Jingsi Chen2, Jifang Liu3
1The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510700, China. yzhbb2012@126.com and Department of Chemical and Materials Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada. hongbo.zeng@ualberta.ca.
Injectable polymer hydrogels offer advanced cancer theranostics by combining therapy and diagnosis in a single injection. This review details their design, components, and performance for personalized, non-invasive patient treatment and monitoring.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Oncology
Background:
- Theranostic platforms integrate diagnostic and therapeutic capabilities for personalized medicine.
- Polymer hydrogels are crucial for controlled drug delivery and targeted therapies.
- Injectable hydrogels offer minimally invasive treatment and monitoring solutions.
Purpose of the Study:
- To review recent advancements in injectable polymer hydrogels for cancer theranostics.
- To focus on the design, components, cross-linking strategies, and performance of these hydrogels.
- To discuss therapeutic agents, tracking modalities, and design approaches for theranostic hydrogels.
Main Methods:
- Review of literature on injectable polymer hydrogels for cancer theranostics.
- Analysis of hydrogel components, cross-linking strategies (chemical bonds and physical interactions).
- Evaluation of drug delivery, tracking capabilities, and overall theranostic performance.
Main Results:
- Injectable polymer hydrogels enable precise control over drug release and enable real-time tracking.
- Hydrogel architecture and components significantly influence theranostic functions.
- Both chemically and physically cross-linked hydrogels demonstrate potential in cancer theranostics.
Conclusions:
- Injectable polymer hydrogels represent a promising platform for developing advanced cancer theranostic systems.
- Further research into hydrogel design and component integration can lead to more effective and personalized cancer therapies.
- Future prospects include enhanced patient comfort and highly individualized treatment strategies.
